5 Design of Medical Experiments
... Patients blinded to treatment For reasons that are not always clear patients can tend to improve more on one type of treatment compared to another, even when it is known that the treatments are identical. This applies to both subjective symptoms such as degree of pain, and even apparently purely phy ...
... Patients blinded to treatment For reasons that are not always clear patients can tend to improve more on one type of treatment compared to another, even when it is known that the treatments are identical. This applies to both subjective symptoms such as degree of pain, and even apparently purely phy ...
Ezetimibe
... • £85 million a year in primary care in England up to June 2010 • Does this represent good value for money and rational expenditure? MeReC’s advice is that we should review, and where appropriate, revise prescribing of ezetimibe to ensure it is in line with NICE guidance ...
... • £85 million a year in primary care in England up to June 2010 • Does this represent good value for money and rational expenditure? MeReC’s advice is that we should review, and where appropriate, revise prescribing of ezetimibe to ensure it is in line with NICE guidance ...
SOMATROPIN for growth hormone deficiencies of
... A dose of 25 to 40micrograms/kg daily is recommended in GH deficiency, 45 to 50micrograms/kg daily in Turner syndrome and CR1 and 35 micrograms/kg daily for children with PWS or who were born SGA. Somatropin is self-administered at home as a subcutaneous injection each evening. Therapy should normal ...
... A dose of 25 to 40micrograms/kg daily is recommended in GH deficiency, 45 to 50micrograms/kg daily in Turner syndrome and CR1 and 35 micrograms/kg daily for children with PWS or who were born SGA. Somatropin is self-administered at home as a subcutaneous injection each evening. Therapy should normal ...
Apicoectomy Treatment
... I understand that following treatment I may experience bleeding, pain, swelling and discomfort for several days, which may be treated with pain medication. It is possible that infection may accompany treatment and must be treated with antibiotics. I will immediately contact the office if my conditio ...
... I understand that following treatment I may experience bleeding, pain, swelling and discomfort for several days, which may be treated with pain medication. It is possible that infection may accompany treatment and must be treated with antibiotics. I will immediately contact the office if my conditio ...
CareCentric End of Life
... their last year of life and makes it available in real time to authorised users across care settings. The electronic record is available to all approved staff when and where it is needed. Known data such as allergies, current medications and adverse drug reactions are pulled through from local syste ...
... their last year of life and makes it available in real time to authorised users across care settings. The electronic record is available to all approved staff when and where it is needed. Known data such as allergies, current medications and adverse drug reactions are pulled through from local syste ...
Modafinil - NHS Trafford CCG
... characterised by uncontrollable daytime sleepiness (also called 'excessive daytime sleepiness') and intermittent abnormal manifestations of rapid eye movement (REM) sleep during wake or sleep-wake transition, of which cataplexy is the most prominent (2). 2. Scope This shared care protocol must be ad ...
... characterised by uncontrollable daytime sleepiness (also called 'excessive daytime sleepiness') and intermittent abnormal manifestations of rapid eye movement (REM) sleep during wake or sleep-wake transition, of which cataplexy is the most prominent (2). 2. Scope This shared care protocol must be ad ...
Methotrexate - Wolverhampton Formulary
... This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of methotrexate for ocular inflammatory diseases can be shared between the specialist and general practitioner (GP). GPs are invited to participate. If the GP is not confident to undertake t ...
... This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of methotrexate for ocular inflammatory diseases can be shared between the specialist and general practitioner (GP). GPs are invited to participate. If the GP is not confident to undertake t ...
? RHEUMATOID ARTHRITIS .– DEFERRED
... ■ MERIDIA (sibutramine hydrochloride monohydrate) (ABB) and XENICAL (orlistat) (HLR) were not recommended for addition to the AHWDBL. With regard to MERIDIA, the Committee referenced the March 2002 Health Canada Advisory that advised that a safety review of this product is currently being undertaken ...
... ■ MERIDIA (sibutramine hydrochloride monohydrate) (ABB) and XENICAL (orlistat) (HLR) were not recommended for addition to the AHWDBL. With regard to MERIDIA, the Committee referenced the March 2002 Health Canada Advisory that advised that a safety review of this product is currently being undertaken ...
Venlafaxine - NHS Trafford CCG
... undertaken with the advice or supervision of a specialist within Mental Health Services or a GP with Special Interest .The prescription of venlafaxine 300mg-375mg is classed as AMBER with shared care arrangements being in place with the continuing supervision and monitoring of the patient. Venlafaxi ...
... undertaken with the advice or supervision of a specialist within Mental Health Services or a GP with Special Interest .The prescription of venlafaxine 300mg-375mg is classed as AMBER with shared care arrangements being in place with the continuing supervision and monitoring of the patient. Venlafaxi ...
Date - Sussex Partnership NHS Foundation Trust
... (Post meeting note – The Coastal West Sussex APC have approved its use as ‘blue’, meaning initiation by a specialist only. This decision was made because NICE approved its use for a first or recurrent major depressive episode only.) 2 of 6 ...
... (Post meeting note – The Coastal West Sussex APC have approved its use as ‘blue’, meaning initiation by a specialist only. This decision was made because NICE approved its use for a first or recurrent major depressive episode only.) 2 of 6 ...
Teriparatide - North East Essex CCG
... Reviewed by: Dr Paul Byrne (Consultant Rheumatologist) and Sheila Baldwin (Head of Medicines Management, NHS North East Essex Clinical Commissioning Group) Approved by: NEEMMC Jan 2015 Next review date: Jan 2017 ...
... Reviewed by: Dr Paul Byrne (Consultant Rheumatologist) and Sheila Baldwin (Head of Medicines Management, NHS North East Essex Clinical Commissioning Group) Approved by: NEEMMC Jan 2015 Next review date: Jan 2017 ...
Methylphenidate SCG – ADHD in Children and Young People
... Giggle Incontinence Children 8-16 years The methylphenidate doses prescribed are 5 – 20mg daily, in divided doses, lower than the usual doses used in ADHD. Its use should be subject to a therapeutic trial to be reviewed after two months and considered for shared care if patients have been shown to r ...
... Giggle Incontinence Children 8-16 years The methylphenidate doses prescribed are 5 – 20mg daily, in divided doses, lower than the usual doses used in ADHD. Its use should be subject to a therapeutic trial to be reviewed after two months and considered for shared care if patients have been shown to r ...
Joint COPD Guidelines
... – use long-acting bronchodilators or LABA + ICS – consider adding theophylline if still symptomatic Offer pulmonary rehabilitation to all suitable people Refer patients who are breathless, have a single large bulla on a CT scan and an FEV1 less than 50% predicted for consideration of bullectomy Refe ...
... – use long-acting bronchodilators or LABA + ICS – consider adding theophylline if still symptomatic Offer pulmonary rehabilitation to all suitable people Refer patients who are breathless, have a single large bulla on a CT scan and an FEV1 less than 50% predicted for consideration of bullectomy Refe ...
TOBI® (nebulised tobramycin)
... (measured as greater than or equal to 4% per year) despite compliance with the standard current practice of nebulised colistin (2MU) or if colistin is not tolerated. Cystic Fibrosis Centre Cardiff state that these patients would also be expected to have had 4 exacerbations requiring IV antibiotics i ...
... (measured as greater than or equal to 4% per year) despite compliance with the standard current practice of nebulised colistin (2MU) or if colistin is not tolerated. Cystic Fibrosis Centre Cardiff state that these patients would also be expected to have had 4 exacerbations requiring IV antibiotics i ...
Degarelix for advanced hormone dependent prostate cancer
... checs (Clinical & Health Economic Commissioning Support) assessments are produced by the operations team of the Peninsula Health Technology Commissioning Group co-ordinated through NHS Devon. This NHS initiative was set up to provide commissioners with high quality evidence in the form of health tec ...
... checs (Clinical & Health Economic Commissioning Support) assessments are produced by the operations team of the Peninsula Health Technology Commissioning Group co-ordinated through NHS Devon. This NHS initiative was set up to provide commissioners with high quality evidence in the form of health tec ...
QA34_6_PregnancyPrescribing
... In general, the use of medications in pregnancy should be avoided where possible, particularly in the first trimester. The use of all medications in pregnancy should follow a careful risk versus benefit assessment. A medication with the best safety record over time should be chosen over a new medica ...
... In general, the use of medications in pregnancy should be avoided where possible, particularly in the first trimester. The use of all medications in pregnancy should follow a careful risk versus benefit assessment. A medication with the best safety record over time should be chosen over a new medica ...
Community Provider
... funding (for example: procedures that are not on the approved list). The form must be completed electronically giving full details. Boxes will expand. Failure to provide full information may result in a delay in reaching a final decision. Your submission will be greatly supported if you directly ans ...
... funding (for example: procedures that are not on the approved list). The form must be completed electronically giving full details. Boxes will expand. Failure to provide full information may result in a delay in reaching a final decision. Your submission will be greatly supported if you directly ans ...
MCP-183 Clinical Trials and Rare Disease Policy
... mental or physical condition; the impairment is expected to result in death and has remained or expected to remain continuously for at least a twelve month period; and No other treatment options are available; other available conventional treatment options have been exhausted without benefit; and ...
... mental or physical condition; the impairment is expected to result in death and has remained or expected to remain continuously for at least a twelve month period; and No other treatment options are available; other available conventional treatment options have been exhausted without benefit; and ...
File - NORTH CENTRAL LONDON: JOINT FORMULARY
... 5. To inform the consultant if the patient discontinues treatment for any reason 6. To seek the advice of the consultant if any concerns with the patient’s therapy 7. To return a copy of the standard letter to the Consultant accepting or declining shared care. If the GP does not agree to shared care ...
... 5. To inform the consultant if the patient discontinues treatment for any reason 6. To seek the advice of the consultant if any concerns with the patient’s therapy 7. To return a copy of the standard letter to the Consultant accepting or declining shared care. If the GP does not agree to shared care ...
SiGMA: Prescribing antipsychotic drugs in schizophrenia
... All dosages should remain within those outlined within the BNF, following their recommendations for initiation and maintenance treatment. High dose prescribing is not advisable. Where undertaken, Royal College of Psychiatrists’ guidelines should be followed. ...
... All dosages should remain within those outlined within the BNF, following their recommendations for initiation and maintenance treatment. High dose prescribing is not advisable. Where undertaken, Royal College of Psychiatrists’ guidelines should be followed. ...
presentation_6-18-2012-21-37-54
... • The evidence most highly valued and ultimately judged to be the best may differ based on which perspective predominates. – efficacy and effectiveness approaches to research. – assumed to be synonyms, the are not – are often used incorrectly • Which question we answer (efficacy or effectiveness) wi ...
... • The evidence most highly valued and ultimately judged to be the best may differ based on which perspective predominates. – efficacy and effectiveness approaches to research. – assumed to be synonyms, the are not – are often used incorrectly • Which question we answer (efficacy or effectiveness) wi ...
Attention Deficit Hyperactivity Disorder (ADHD)
... to formal psychotherapeutic interventions. There may be need for dietary intervention where a parent has observed that a particular food aggravates the symptoms. Medications that are currently licensed for the treatment of ADHD in the UK are the CNS stimulants methylphenidate and dexamphetamine and ...
... to formal psychotherapeutic interventions. There may be need for dietary intervention where a parent has observed that a particular food aggravates the symptoms. Medications that are currently licensed for the treatment of ADHD in the UK are the CNS stimulants methylphenidate and dexamphetamine and ...
Researchers and Medicaid Medical Directors
... Is it as safe, safer, or have different risks? Is it as effective or significantly more effective than current practice Are patients likely to demand this over what is currently offered ...
... Is it as safe, safer, or have different risks? Is it as effective or significantly more effective than current practice Are patients likely to demand this over what is currently offered ...
Venlafaxine – SCG High Dose
... Authorised by Greater Manchester West Mental Health NHS Foundation Trust MMG July 2010 ...
... Authorised by Greater Manchester West Mental Health NHS Foundation Trust MMG July 2010 ...